Basit öğe kaydını göster

dc.contributor.authorBatur, Sebnem
dc.contributor.authorYilmaz-Aydogan, Hülya
dc.contributor.authorDiren, Ayca
dc.contributor.authorOzturk, Oguz
dc.contributor.authorIsbir, Turgay
dc.contributor.authorOzturk, Tulin
dc.contributor.authorKain, Ecem Zeynep
dc.contributor.authorTuzuner, Mete Bora
dc.date.accessioned2021-12-10T12:00:43Z
dc.date.available2021-12-10T12:00:43Z
dc.date.issued2021
dc.identifier.citationOzturk T., Kain E. Z. , Tuzuner M. B. , Diren A., Batur S., Yilmaz-Aydogan H., Ozturk O., Isbir T., "Kallikrein 11 Down-regulation in Breast Carcinoma: Correlation With Prognostic Parameters.", In vivo (Athens, Greece), cilt.35, sa.6, ss.3233-3243, 2021
dc.identifier.issn0258-851X
dc.identifier.othervv_1032021
dc.identifier.otherav_a2e741b3-fc16-4b66-a144-c319326e697d
dc.identifier.urihttp://hdl.handle.net/20.500.12627/173074
dc.identifier.urihttps://avesis.istanbul.edu.tr/api/publication/a2e741b3-fc16-4b66-a144-c319326e697d/file
dc.identifier.urihttps://doi.org/10.21873/invivo.12618
dc.description.abstractBackground: Expression of kallikrein-11 (KLK11) has been found to be related to the prognosis of various human cancer types but its physiological functions in the steps of breast cancer (BC) progression are still unknown. Materials and Methods: BC and adjacent normal breast tissue samples were collected from 28 patients. KLK11 expression levels were determined by real-time polymerase chain reaction for each sample and associations with known prognostic features were statistically analyzed. Results: Although there was slight up-regulation in tumor tissues overall, significant down-regulation of KLK11 expression in tumor tissue was observed in the elderly and in patients with perineural invasion. Furthermore, tumor size, grade, mitotic score, necrosis, calcification, lymphatic invasion, hormone receptor status and Ki67 expression were associated with altered KLK11 level. Conclusion: Changes in expression levels of KLK11, associated with patient characteristics, might be used as complementary data in order to predict clinical outcome and prognosis in BC.
dc.language.isoeng
dc.subjectTIP, ARAŞTIRMA VE DENEYSEL
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.titleKallikrein 11 Down-regulation in Breast Carcinoma: Correlation With Prognostic Parameters.
dc.typeMakale
dc.relation.journalIn vivo (Athens, Greece)
dc.contributor.department, ,
dc.identifier.volume35
dc.identifier.issue6
dc.identifier.startpage3233
dc.identifier.endpage3243
dc.contributor.firstauthorID2754837


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster